Nanoparticles Targeting Macrophages as Potential Clinical Therapeutic Agents Against Cancer and Inflammation

With the development of nanotechnology, significant progress has been made in the design, and manufacture of nanoparticles (NPs) for use in clinical treatments. Recent increases in our understanding of the central role of macrophages in the context of inflammation and cancer have reinvigorated inter...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Guorong, Guo, Mengfei, Xu, Juanjuan, Wu, Feng, Fan, Jinshuo, Huang, Qi, Yang, Guanghai, Lv, Zhilei, Wang, Xuan, Jin, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712945/
https://www.ncbi.nlm.nih.gov/pubmed/31497026
http://dx.doi.org/10.3389/fimmu.2019.01998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712945/
https://www.ncbi.nlm.nih.gov/pubmed/31497026
http://dx.doi.org/10.3389/fimmu.2019.01998

Ejemplares similares